WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H317453
CAS#: 68401-82-1 (sodium)
Description: Ceftizoxime is third generation cephalosporin effective against Gram-negative and Gram-positive bacteria. It binds penicillin-binding proteins (PBPs) and inhibits the bacterial cell wall synthesis. Unlike other third-generation cephalosporins, the whole C-3 side chain in ceftizoxime has been removed to prevent deactivation by hydrolytic enzymes. It rather resembles cefotaxime in its properties, but is not subject to metabolism.
Hodoodo Cat#: H317453
Name: Ceftizoxime Sodium
CAS#: 68401-82-1 (sodium)
Chemical Formula: C13H12N5NaO5S2
Exact Mass: 0.00
Molecular Weight: 405.380
Elemental Analysis: C, 38.52; H, 2.98; N, 17.28; Na, 5.67; O, 19.73; S, 15.82
Related CAS #: 68401-82-1 (sodium) 68401-81-0 (free acid)
Synonym: Ceftizoxime Sodium; Ceftizoxim-natrium; Cefizox; Epocelin; Eposerin; Ceftizoxime sodium salt; Monosodium Salt, Ceftizoxime; Salt, Ceftizoxime Monosodium; SK and F 88373 2; SK and F 88373-2; SK and F 883732; SKF 88373; SKF-88373; SKF88373;
IUPAC/Chemical Name: sodium;(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
InChi Key: ADLFUPFRVXCDMO-LIGXYSTNSA-M
InChi Code: InChI=1S/C13H13N5O5S2.Na/c1-23-17-7(5-4-25-13(14)15-5)9(19)16-8-10(20)18-6(12(21)22)2-3-24-11(8)18;/h2,4,8,11H,3H2,1H3,(H2,14,15)(H,16,19)(H,21,22);/q;+1/p-1/b17-7-;/t8-,11-;/m1./s1
SMILES Code: CO/N=C(/C1=CSC(=N1)N)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=CCS3)C(=O)[O-].[Na+]
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO, not in water
Shelf Life: >2 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info:
| Biological target: | |
| In vitro activity: | |
| In vivo activity: |
The following data is based on the product molecular weight 405.38 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
| Formulation protocol: | |
| In vitro protocol: | |
| In vivo protocol: |
1: Bhat AM, Soodan JS, Singh R, Dhobi IA, Hussain T, Dar MY, Mir M. Incidence of bovine clinical mastitis in Jammu region and antibiogram of isolated pathogens. Vet World. 2017 Aug;10(8):984-989. doi: 10.14202/vetworld.2017.984-989. Epub 2017 Aug 25. PubMed PMID: 28919694; PubMed Central PMCID: PMC5591490.
2: Liu S, Wang C, Fu YX. [Analysis of drug resistance of Acinetobacter baumannii in wound of children with traffic injury and its relationship with antibiotic use]. Zhonghua Shao Shang Za Zhi. 2017 Jul 20;33(7):404-409. doi: 10.3760/cma.j.issn.1009-2587.2017.07.002. Chinese. PubMed PMID: 28763905.
3: Hashizume H, Takahashi Y, Masuda T, Ohba SI, Ohishi T, Kawada M, Igarashi M. In vivo efficacy of β-lactam/tripropeptin C in a mouse septicemia model and the mechanism of reverse β-lactam resistance in methicillin-resistant Staphylococcus aureus mediated by tripropeptin C. J Antibiot (Tokyo). 2017 Jul 26. doi: 10.1038/ja.2017.88. [Epub ahead of print] PubMed PMID: 28743973.
4: Adesida SA, Ezenta CC, Adagbada AO, Aladesokan AA, Coker AO. CARRIAGE OF MULTIDRUG RESISTANT ENTEROCOCCUS FAECIUM AND ENTEROCOCCUS FAECALIS AMONG APPARENTLY HEALTHY HUMANS. Afr J Infect Dis. 2017 Jun 8;11(2):83-89. doi: 10.21010/ajid.v11i2.11. eCollection 2017. PubMed PMID: 28670644; PubMed Central PMCID: PMC5476817.
5: Jabeen S, Hassan F, Yousuf RI, Shoaib MH, Israr F, Hasan SMF, Saeed R, Farooqi S. Impact of different organic acids on solubility enhancement of cefpodxime proxetil immediate release tablet and its stability studies. Pak J Pharm Sci. 2017 May;30(3):855-866. PubMed PMID: 28653931.
6: Piccinelli G, Carlentini G, Gargiulo F, Caruso A, De Francesco MA. Analysis of Point Mutations in the pbp2x, pbp2b, and pbp1a Genes of Streptococcus agalactiae and Their Relation with a Reduced Susceptibility to Cephalosporins. Microb Drug Resist. 2017 Dec;23(8):1019-1024. doi: 10.1089/mdr.2017.0013. Epub 2017 Apr 12. PubMed PMID: 28402182.
7: Mujtaba A, Kohli K. Validated HPLC method for the pharmacokinetic study of oral extended-release cefpodoxime proxetil chitosan-alginate beads in rabbits. Int J Biol Macromol. 2017 May;98:111-116. doi: 10.1016/j.ijbiomac.2017.01.099. Epub 2017 Jan 27. PubMed PMID: 28137463.
8: Ren G, Zhou M, Ding N, Zhou N, Li Q. Analysis on distribution features and drug resistance of clinically isolated Acinetobacter baumannii. Exp Ther Med. 2016 Sep;12(3):1715-1718. Epub 2016 Jul 11. PubMed PMID: 27602085; PubMed Central PMCID: PMC4998347.
9: El-Jade MR, Parcina M, Schmithausen RM, Stein C, Meilaender A, Hoerauf A, Molitor E, Bekeredjian-Ding I. ESBL Detection: Comparison of a Commercially Available Chromogenic Test for Third Generation Cephalosporine Resistance and Automated Susceptibility Testing in Enterobactericeae. PLoS One. 2016 Aug 5;11(8):e0160203. doi: 10.1371/journal.pone.0160203. eCollection 2016. PubMed PMID: 27494134; PubMed Central PMCID: PMC4975492.
10: Garbacki P, Cielecka-Piontek J, Zalewski P, Oszczapowicz I, Jelińska A. A SIMPLE AND-SENSITIVE STABILITY-INDICATING UHPLC-DAD METHOD FOR THE DETERMINATION OF CEFETAMET PIVOXIL HYDROCHLORIDE. Acta Pol Pharm. 2016 May-Jun;73(3):621-6. PubMed PMID: 27476279.
11: Ganesh T, Kannappan V, Mohamed Kamil MG, Kumar R. Investigation of molecular interaction between cefpodoxime acid and human mixtard insulin by ultrasonic and spectral methods. J Pharm Biomed Anal. 2016 Sep 10;129:237-245. doi: 10.1016/j.jpba.2016.07.007. Epub 2016 Jul 7. PubMed PMID: 27442885.
12: Chen YT, Ahmad Murad K, Ng LS, Seah JT, Park JJ, Tan TY. In Vitro Efficacy of Six Alternative Antibiotics against Multidrug Resistant Escherichia Coli and Klebsiella Pneumoniae from Urinary Tract Infections. Ann Acad Med Singapore. 2016 Jun;45(6):245-50. PubMed PMID: 27412057.
13: Guneysel O, Suman E, Ozturk TC. TRIMETHOPRIM-SULFAMETHOXAZOLE RESISTANCE AND FOSFOMYCIN SUSCEPTIBILITY RATES IN UNCOMPLICATED URINARY TRACT INFECTIONS: TIME TO CHANGE THE ANTIMICROBIAL PREFERENCES. Acta Clin Croat. 2016 Mar;55(1):49-57. PubMed PMID: 27333718.
14: Mujtaba A, Kohli K. In vitro/in vivo evaluation of HPMC/alginate based extended-release matrix tablets of cefpodoxime proxetil. Int J Biol Macromol. 2016 Aug;89:434-41. doi: 10.1016/j.ijbiomac.2016.05.010. Epub 2016 May 4. PubMed PMID: 27155235.
15: Holroyd KB, Rittenberg A, Pahwa A. Misanalysis of Urinalysis: A Teachable Moment. JAMA Intern Med. 2016 Apr;176(4):432-3. doi: 10.1001/jamainternmed.2016.0067. PubMed PMID: 26954774.
16: Wang L, Zheng X, Zhong W, Chen J, Jiang J, Hu P. Validation and Application of an LC-MS-MS Method for the Determination of Ceftizoxime in Human Serum and Urine. J Chromatogr Sci. 2016 May-Jun;54(5):713-9. doi: 10.1093/chromsci/bmv243. Epub 2016 Feb 18. PubMed PMID: 26896348; PubMed Central PMCID: PMC4890441.
17: Kafil HS, Mobarez AM, Moghadam MF, Hashemi ZS, Yousefi M. Gentamicin induces efaA expression and biofilm formation in Enterococcus faecalis. Microb Pathog. 2016 Mar;92:30-35. doi: 10.1016/j.micpath.2015.12.008. Epub 2015 Dec 25. PubMed PMID: 26724739.
18: Blane B, Brodrick HJ, Gouliouris T, Ambridge KE, Kidney AD, Ludden CM, Limmathurotsakul D, Török ME, Peacock SJ. Comparison of 2 chromogenic media for the detection of extended-spectrum β-lactamase producing Enterobacteriaceae stool carriage in nursing home residents. Diagn Microbiol Infect Dis. 2016 Mar;84(3):181-3. doi: 10.1016/j.diagmicrobio.2015.11.008. Epub 2015 Nov 11. PubMed PMID: 26712266; PubMed Central PMCID: PMC4769092.
19: Almeida RA, Hasimoto CN, Kim A, Hasimoto EN, El Dib R. Antibiotic prophylaxis for surgical site infection in people undergoing liver transplantation. Cochrane Database Syst Rev. 2015 Dec 5;(12):CD010164. doi: 10.1002/14651858.CD010164.pub2. Review. PubMed PMID: 26637264.
20: Costa PH, Diniz SO, Cardoso VN, Tarabal B, Takenaka I, Braga O, Vidigal PV, Gelape CL, Araujo ID. Scintigraphic imaging with technetium-99M-labelled ceftizoxime is a reliable technique for the diagnosis of deep sternal wound infection in rats. Acta Cir Bras. 2015 Sep;30(9):632-8. doi: 10.1590/S0102-865020150090000008. PubMed PMID: 26465108.
